申请人:MERCK SHARP & DOHME LTD.
公开号:EP0485026A2
公开(公告)日:1992-05-13
A class of substituted phenoxymethylene bisphosphonate derivatives inhibit the action of inositol monophosphatase enzymes and are therefore useful in the treatment and/or prevention of bipolar and nonbipolar depressive disorders, and psychotic disorders other than mania, without exhibiting the spectrum of severe side-effects customarily associated with lithium treatment.
一类取代苯氧甲烷双磷酸酯衍生物抑制肌醇一磷酸酶酶的作用,因此在治疗和/或预防双相和非双相抑郁症以及精神病性障碍(不包括躁狂症)方面非常有用,而不表现出通常与锂治疗相关的严重副作用谱。